These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 24997145)
1. ETV6 mutation in a cohort of 970 patients with hematologic malignancies. Wang Q; Dong S; Yao H; Wen L; Qiu H; Qin L; Ma L; Chen S Haematologica; 2014 Oct; 99(10):e176-8. PubMed ID: 24997145 [No Abstract] [Full Text] [Related]
2. Germline ETV6 mutations in familial thrombocytopenia and hematologic malignancy. Zhang MY; Churpek JE; Keel SB; Walsh T; Lee MK; Loeb KR; Gulsuner S; Pritchard CC; Sanchez-Bonilla M; Delrow JJ; Basom RS; Forouhar M; Gyurkocza B; Schwartz BS; Neistadt B; Marquez R; Mariani CJ; Coats SA; Hofmann I; Lindsley RC; Williams DA; Abkowitz JL; Horwitz MS; King MC; Godley LA; Shimamura A Nat Genet; 2015 Feb; 47(2):180-5. PubMed ID: 25581430 [TBL] [Abstract][Full Text] [Related]
3. ETV6 fusion genes in hematological malignancies: a review. De Braekeleer E; Douet-Guilbert N; Morel F; Le Bris MJ; Basinko A; De Braekeleer M Leuk Res; 2012 Aug; 36(8):945-61. PubMed ID: 22578774 [TBL] [Abstract][Full Text] [Related]
4. Identification of the nuclear localization motif in the ETV6 (TEL) protein. Park H; Seo Y; Kim JI; Kim WJ; Choe SY Cancer Genet Cytogenet; 2006 Jun; 167(2):117-21. PubMed ID: 16737910 [TBL] [Abstract][Full Text] [Related]
6. ETV6: a versatile player in leukemogenesis. Bohlander SK Semin Cancer Biol; 2005 Jun; 15(3):162-74. PubMed ID: 15826831 [TBL] [Abstract][Full Text] [Related]
7. Mutation of the salt bridge-forming residues in the ETV6-SAM domain interface blocks ETV6-NTRK3-induced cellular transformation. Cetinbas N; Huang-Hobbs H; Tognon C; Leprivier G; An J; McKinney S; Bowden M; Chow C; Gleave M; McIntosh LP; Sorensen PH J Biol Chem; 2013 Sep; 288(39):27940-50. PubMed ID: 23798677 [TBL] [Abstract][Full Text] [Related]
9. Genomic aberrations involving 12p/ETV6 are highly prevalent in blastic plasmacytoid dendritic cell neoplasms and might represent early clonal events. Tang Z; Li Y; Wang W; Yin CC; Tang G; Aung PP; Hu S; Lu X; Toruner GA; Medeiros LJ; Khoury JD Leuk Res; 2018 Oct; 73():86-94. PubMed ID: 30248580 [TBL] [Abstract][Full Text] [Related]
10. ETV6 and signaling gene mutations are associated with secondary transformation of myelodysplastic syndromes to chronic myelomonocytic leukemia. Padron E; Yoder S; Kunigal S; Mesa T; Teer JK; Al Ali N; Sekeres MA; Painter JS; Zhang L; Lancet J; Maciejewski JP; Epling-Burnette PK; Sotomayor E; Komrokji RS; List AF Blood; 2014 Jun; 123(23):3675-7. PubMed ID: 24904105 [No Abstract] [Full Text] [Related]
11. ETV6 mutations define a new cancer predisposition syndrome. Kirkpatrick G; Noetzli L; Di Paola J; Porter CC Oncotarget; 2015 Jul; 6(19):16830-1. PubMed ID: 26219557 [No Abstract] [Full Text] [Related]
12. ETV6-related thrombocytopenia associated with a transient decrease in von Willebrand factor. Kanamaru Y; Uchiyama T; Kaname T; Yanagi K; Ohara O; Kunishima S; Ishiguro A Int J Hematol; 2021 Aug; 114(2):297-300. PubMed ID: 33768492 [TBL] [Abstract][Full Text] [Related]
13. ETV6 in hematopoiesis and leukemia predisposition. Hock H; Shimamura A Semin Hematol; 2017 Apr; 54(2):98-104. PubMed ID: 28637624 [TBL] [Abstract][Full Text] [Related]
14. Response of ETV6-FLT3-positive myeloid/lymphoid neoplasm with eosinophilia to inhibitors of FMS-like tyrosine kinase 3. Walz C; Erben P; Ritter M; Bloor A; Metzgeroth G; Telford N; Haferlach C; Haferlach T; Gesk S; Score J; Hofmann WK; Hochhaus A; Cross NC; Reiter A Blood; 2011 Aug; 118(8):2239-42. PubMed ID: 21705501 [TBL] [Abstract][Full Text] [Related]
15. Biophysical characterization of the ETV6 PNT domain polymerization interfaces. Gerak CAN; Cho SY; Kolesnikov M; Okon M; Murphy MEP; Sessions RB; Roberge M; McIntosh LP J Biol Chem; 2021; 296():100284. PubMed ID: 33450226 [TBL] [Abstract][Full Text] [Related]
16. Fluorescence in situ hybridization characterization of new translocations involving TEL (ETV6) in a wide spectrum of hematologic malignancies. Wlodarska I; La Starza R; Baens M; Dierlamm J; Uyttebroeck A; Selleslag D; Francine A; Mecucci C; Hagemeijer A; Van den Berghe H; Marynen P Blood; 1998 Feb; 91(4):1399-406. PubMed ID: 9454771 [TBL] [Abstract][Full Text] [Related]
17. ETV6 mutations and loss in AML-M0. Silva FP; Morolli B; Storlazzi CT; Zagaria A; Impera L; Klein B; Vrieling H; Kluin-Nelemans HC; Giphart-Gassler M Leukemia; 2008 Aug; 22(8):1639-43. PubMed ID: 18305557 [No Abstract] [Full Text] [Related]
18. ETV6-NCOA2: a novel fusion gene in acute leukemia associated with coexpression of T-lymphoid and myeloid markers and frequent NOTCH1 mutations. Strehl S; Nebral K; König M; Harbott J; Strobl H; Ratei R; Struski S; Bielorai B; Lessard M; Zimmermann M; Haas OA; Izraeli S Clin Cancer Res; 2008 Feb; 14(4):977-83. PubMed ID: 18281529 [TBL] [Abstract][Full Text] [Related]
19. ETV6-related thrombocytopenia and leukemia predisposition. Di Paola J; Porter CC Blood; 2019 Aug; 134(8):663-667. PubMed ID: 31248877 [TBL] [Abstract][Full Text] [Related]